Clozapine

Clozapine use and outcomes among patients with treatment resistant schizophrenia.

El-Badri S, Mellsop G. Clozapine use and outcomes among patients with treatment resistant schizophrenia. Australas Psychiatry. 2011;19(5):410-4. DOI: 10.3109/10398562.2011.602078. PubMed PMID: 21864010.

Addressing nonresponse in schizophrenia.

Kane JM. Addressing nonresponse in schizophrenia. J Clin Psychiatry. 2012;73(2):e07. DOI: 10.4088/JCP.11076tx2c. PubMed PMID: 22401484.

Nonresponse to clozapine and premorbid functioning in treatment of refractory schizophrenia.

Kelly DL, Feldman S, Boggs DL, Gale E, Conley RR. Nonresponse to clozapine and premorbid functioning in treatment of refractory schizophrenia. Compr Psychiatry. 2010;51(3):298-302. DOI: 10.1016/j.comppsych.2009.07.003. PubMed PMID: 20399340.

Early response to clozapine in schizophrenia.

Stern RG, Kahn RS, Davidson M, Nora RM, Davis KL. Early response to clozapine in schizophrenia. Am J Psychiatry. 1994;151(12):1817-8. PubMed PMID: 7977893.

Predictors of differential response to clozapine and haloperidol. Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.

Rosenheck R, Lawson W, Crayton J, Cramer J, Xu W, Thomas J, et al. Predictors of differential response to clozapine and haloperidol. Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Biol Psychiatry. 1998;44(6):475-82. PubMed PMID: 9777179.

How long to wait for a response to clozapine: a comparison of time course of response to clozapine and conventional antipsychotic medication in refractory schizophrenia.

Rosenheck R, Evans D, Herz L, Cramer J, Xu W, Thomas J, et al. How long to wait for a response to clozapine: a comparison of time course of response to clozapine and conventional antipsychotic medication in refractory schizophrenia. Schizophr Bull. 1999;25(4):709-19. PubMed PMID: 10667741.

Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.

Semiz UB, Cetin M, Basoglu C, Ebrinc S, Uzun O, Herken H, et al. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(6):1330-6. DOI: 10.1016/j.pnpbp.2007.06.002. PubMed PMID: 17618026.

Predictors of response in a sample of treatment-resistant psychotic patients on clozapine.

Ciapparelli A, Ducci F, Carmassi C, Carlini M, Paggini R, Catena M, et al. Predictors of response in a sample of treatment-resistant psychotic patients on clozapine. Eur Arch Psychiatry Clin Neurosci. 2004;254(5):343-6. DOI: 10.1007/s00406-004-0511-4. PubMed PMID: 15365711.

Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: evidence from a therapeutic drug monitoring service.

Jerling M, Lindström L, Bondesson U, Bertilsson L. Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: evidence from a therapeutic drug monitoring service. Ther Drug Monit. 1994;16(4):368-74. PubMed PMID: 7974626.

Clozapine levels and caffeine.

Odom-White A, de Leon J. Clozapine levels and caffeine. J Clin Psychiatry. 1996;57(4):175-6. PubMed PMID: 8601555.